• Plasmid construction and site directed mutagenesis of

  2022-01-03

  

  Plasmid construction and site-directed mutagenesis of M. luteus B-P 26 UPS. For the expression of N-terminus His6-tagged M. luteus B-P 26 UPS, the expression plasmid pMluUEX [7] was cleaved with the restriction enzymes NdeI/BamHI. The gene fragment was inserted into an NdeI/BamHI-treated pET-15b to

• Hyperhomocysteinemia HHcy is a clinical condition characteri

  2022-01-03

  

  Hyperhomocysteinemia (HHcy) is a clinical condition characterized by increased levels of plasma homocysteine (Hcy) and a well-known risk factor for CVDs. Hcy is a sulfur-containing non-protein amino lysophosphatidic acid australia formed during the intracellular conversion of methionine to cysteine.

• One of the possibilities of HO targeting

  2022-01-03

  

  One of the possibilities of HO-1 targeting is gene therapy. So far, the majority of preclinical studies have focused on recombinant adeno-associated viral (rAAV) vectors as DNA carriers. They not only provide stable, long-term transgene expression in non-dividing flavin adenine dinucleotide australi

7983 records 533/533 page Previous First page 上5页 531532533